Position in BBNX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$11,021,587
+$7,943,154 QoQ
Shares Held
703,356
+128.9% QoQ
Ownership
1.56%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 133 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in BBNX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $14,248,837,970 across 100 Medical Devices names. BBNX ranks #26 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
17,260,943 | $5,434,435,284 | |
| 2 | MDT |
Medtronic plc
|
27,784,471 | $2,173,579,157 | |
| 3 | EW |
Edwards Lifesciences Corp
|
22,783,175 | $2,060,966,003 | |
| 4 | ABT |
Abbott Laboratories
|
15,095,898 | $1,369,801,775 | |
| 5 | BSX |
Boston Scientific Corp
|
23,907,838 | $1,020,386,517 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
10,329,164 | $661,169,779 | |
| 7 | PEN |
Penumbra Inc
|
1,071,454 | $338,311,597 | |
| 8 | DXCM |
Dexcom Inc
|
3,325,095 | $223,945,140 |
All Filings in BBNX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,021,587 | 703,356 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $3,078,433 | 307,229 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $10,624,004 | 348,671 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $4,092,324 | 205,955 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $89,834 | 6,170 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $76,622 | 6,260 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||